Home
>
National Drug Code (NDC)
>
Mitoxantrone
Mitoxantrone - 61703-343-18 - (MITOXANTRONE HYDROCHLORIDE)
Drug Information of Mitoxantrone
| Product NDC: | 61703-343 |
| Proprietary Name: | Mitoxantrone |
| Non Proprietary Name: | MITOXANTRONE HYDROCHLORIDE |
| Active Ingredient(s): | 2 mg/mL & nbsp; MITOXANTRONE HYDROCHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mitoxantrone
| Product NDC: | 61703-343 |
| Labeler Name: | Hospira Worldwide, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076871 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060411 |
Package Information of Mitoxantrone
| Package NDC: | 61703-343-18 |
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (61703-343-18) |
NDC Information of Mitoxantrone
| NDC Code | 61703-343-18 |
| Proprietary Name | Mitoxantrone |
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (61703-343-18) |
| Product NDC | 61703-343 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MITOXANTRONE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20060411 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira Worldwide, Inc. |
| Substance Name | MITOXANTRONE HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
